EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 141 filers reported holding EDGEWISE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 0.12 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $10,445,800 | -13.9% | 580,000 | -12.8% | 2.39% | -9.7% |
| Q1 2024 | $12,129,600 | +58.6% | 665,000 | -4.9% | 2.64% | +30.0% |
| Q4 2023 | $7,647,060 | +52.5% | 699,000 | -20.2% | 2.03% | +24.6% |
| Q3 2023 | $5,016,071 | -20.6% | 875,405 | +7.4% | 1.63% | +8.0% |
| Q2 2023 | $6,316,250 | +26.3% | 815,000 | +8.7% | 1.51% | +0.9% |
| Q1 2023 | $5,002,500 | -8.5% | 750,000 | +22.7% | 1.50% | -21.2% |
| Q4 2022 | $5,465,916 | -12.5% | 611,400 | -3.7% | 1.90% | -26.3% |
| Q3 2022 | $6,248,000 | +73.9% | 635,000 | +40.7% | 2.58% | +59.3% |
| Q2 2022 | $3,593,000 | +22.3% | 451,400 | +49.0% | 1.62% | +77.4% |
| Q1 2022 | $2,939,000 | – | 303,000 | – | 0.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $27,981,435 | 34.02% |
| Novo Holdings A/S | 6,344,430 | $114,263,184 | 6.63% |
| Orbimed Advisors | 15,021,721 | $270,541,195 | 5.34% |
| TCG Crossover Management, LLC | 2,272,728 | $40,931,831 | 4.27% |
| Frazier Life Sciences Management, L.P. | 3,731,067 | $67,196,517 | 3.14% |
| Cormorant Asset Management, LP | 3,006,534 | $54,147,677 | 3.13% |
| Opaleye Management Inc. | 580,000 | $10,445,800 | 2.39% |
| RA Capital Management | 8,909,091 | $160,452,729 | 2.12% |
| VR Adviser, LLC | 1,818,182 | $32,745,458 | 2.08% |
| MPM BioImpact LLC | 740,661 | $13,339,305 | 2.07% |